163 related articles for article (PubMed ID: 24689859)
1. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
[No Abstract] [Full Text] [Related]
4. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
6. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
Izadi S; Salehi M
Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.
Hekimoğlu HC; Demirci NA
Afr Health Sci; 2014 Dec; 14(4):873-81. PubMed ID: 25834496
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
10. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.
Dokuzoguz B; Celikbas AK; Gök ŞE; Baykam N; Eroglu MN; Ergönül Ö
Clin Infect Dis; 2013 Nov; 57(9):1270-4. PubMed ID: 23946218
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
13. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.
Sharifi-Mood B; Metanat M; Ghorbani-Vaghei A; Fayyaz-Jahani F; Akrami E
Arch Iran Med; 2009 Mar; 12(2):151-3. PubMed ID: 19249885
[TBL] [Abstract][Full Text] [Related]
14. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
[TBL] [Abstract][Full Text] [Related]
17. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
Kalın G; Metan G; Demiraslan H; Doganay M
J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
[TBL] [Abstract][Full Text] [Related]
19. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.
Ergonul O
J Infect; 2009 Oct; 59(4):284-6; author reply 286-9. PubMed ID: 19699762
[No Abstract] [Full Text] [Related]
20. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
